{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T12:31:23Z","timestamp":1774787483894,"version":"3.50.1"},"publisher-location":"New York, NY","reference-count":26,"publisher":"Springer New York","isbn-type":[{"value":"9781493933587","type":"print"},{"value":"9781493933600","type":"electronic"}],"license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016]]},"DOI":"10.1007\/978-1-4939-3360-0_1","type":"book-chapter","created":{"date-parts":[[2016,2,3]],"date-time":"2016-02-03T02:59:02Z","timestamp":1454468342000},"page":"1-16","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["A Targeted Q-PCR-Based Method for Point Mutation Testing by Analyzing Circulating DNA for Cancer Management Care"],"prefix":"10.1007","author":[{"given":"Alain R.","family":"Thierry","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,2,4]]},"reference":[{"issue":"3\u20134","key":"1_CR1","first-page":"241","volume":"142","author":"P Mandel","year":"1948","unstructured":"Mandel P, Metais P (1948) C R Seances Soc Biol Fil 142(3\u20134):241\u2013243","journal-title":"C R Seances Soc Biol Fil"},{"issue":"3","key":"1_CR2","first-page":"646","volume":"37","author":"SA Leon","year":"1977","unstructured":"Leon SA, Shapiro B, Sklaroff DM, Yaros MJ (1977) Free DNA in the serum of cancer patients and the effect of therapy. Cancer Res 37(3):646\u2013650","journal-title":"Cancer Res"},{"issue":"6","key":"1_CR3","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0277-5379(87)90266-5","volume":"23","author":"M Stroun","year":"1987","unstructured":"Stroun M, Anker P, Lyautey J, Lederrey C, Maurice PA (1987) Isolation and characterization of DNA of cancer patients. Eur J Cancer Clin Oncol 23(6):707\u2013712","journal-title":"Eur J Cancer Clin Oncol"},{"issue":"61","key":"1_CR4","doi-asserted-by":"publisher","first-page":"61ra91","DOI":"10.1126\/scitranslmed.3001720","volume":"2","author":"YMD Lo","year":"2010","unstructured":"Lo YMD, Chan KCA, Sun H, Chen EZ, Jiang PY, Lun FMF et al (2010) Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2(61):61ra91","journal-title":"Sci Transl Med"},{"issue":"1","key":"1_CR5","first-page":"181","volume":"1775","author":"M Fleischhacker","year":"2007","unstructured":"Fleischhacker M, Schmidt B (2007) Circulating nucleic acids (CNAs) and cancer \u2013 a survey. Biochim Biophys Acta 1775(1):181\u2013232","journal-title":"Biochim Biophys Acta"},{"issue":"1\u20132","key":"1_CR6","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.cca.2008.05.006","volume":"395","author":"M Vaart van der","year":"2008","unstructured":"van der Vaart M, Pretorius PJ (2008) Characterization of circulating DNA in healthy human plasma. Clin Chim Acta 395(1\u20132):186","journal-title":"Clin Chim Acta"},{"issue":"21\u201322","key":"1_CR7","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.cca.2010.07.032","volume":"411","author":"K Jung","year":"2010","unstructured":"Jung K, Fleischhacker M, Rabien A (2010) Cell-free DNA in the blood as a solid tumor biomarker--a critical appraisal of the literature. Clin Chim Acta 411(21\u201322):1611\u20131624","journal-title":"Clin Chim Acta"},{"key":"1_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1196\/annals.1448.034","volume":"1137","author":"B Schmidt","year":"2008","unstructured":"Schmidt B, Weickmann S, Witt C, Fleischhacker M (2008) Integrity of cell-free plasma DNA in patients with lung cancer and nonmalignant lung disease. Ann N Y Acad Sci 1137:207\u2013213","journal-title":"Ann N Y Acad Sci"},{"issue":"1","key":"1_CR9","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.juro.2008.08.118","volume":"181","author":"J Ellinger","year":"2009","unstructured":"Ellinger J, Wittkarnp V, Albers P, Perabo FGE, Mueller SC, von Ruecker A et al (2009) Cell-Free Circulating DNA: Diagnostic Value in Patients With Testicular Germ Cell Cancer. J Urol 181(1):363\u2013371","journal-title":"J Urol"},{"issue":"18","key":"1_CR10","doi-asserted-by":"publisher","first-page":"6159","DOI":"10.1093\/nar\/gkq421","volume":"38","author":"AR Thierry","year":"2010","unstructured":"Thierry AR, Mouliere F, Gongora C, Ollier J, Robert B, Ychou M et al (2010) Origin and quantification of circulating DNA in mice with human colorectal cancer xenografts. Nucleic Acids Res 38(18):6159\u20136175","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"1_CR11","doi-asserted-by":"publisher","first-page":"e23418","DOI":"10.1371\/journal.pone.0023418","volume":"6","author":"F Mouliere","year":"2011","unstructured":"Mouliere F, Robert B, Peyrotte E, Del Rio M, Ychou M, Molina F et al (2011) High fragmentation characterizes tumour-derived circulating DNA. Plos One 6(9):e23418","journal-title":"Plos One"},{"issue":"6","key":"1_CR12","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1038\/nrc3066","volume":"11","author":"H Schwarzenbach","year":"2011","unstructured":"Schwarzenbach H, Hoon DSB, Pantel K (2011) Cell-free nucleic acids as biomarkers in cancer patients. Nat Rev Cancer 11(6):426\u2013437","journal-title":"Nat Rev Cancer"},{"issue":"5","key":"1_CR13","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.molonc.2014.02.005","volume":"8","author":"F Mouliere","year":"2014","unstructured":"Mouliere F, El Messaoudi S, Pang D, Dritschilo A, Thierry AR (2014) Multi-marker analysis of circulating cell-free DNA toward personalized medicine for colorectal cancer. Mol Oncol 8(5):927\u2013941","journal-title":"Mol Oncol"},{"issue":"9","key":"1_CR14","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1038\/nm.1789","volume":"14","author":"F Diehl","year":"2008","unstructured":"Diehl F, Schmidt K, Choti MA, Romans K, Goodman S, Li M et al (2008) Circulating mutant DNA to assess tumor dynamics. Nat Med 14(9):985\u2013990","journal-title":"Nat Med"},{"issue":"13","key":"1_CR15","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1056\/NEJMoa1213261","volume":"368","author":"SJ Dawson","year":"2013","unstructured":"Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF et al (2013) Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 368(13):1199\u20131209","journal-title":"N Engl J Med"},{"issue":"224","key":"1_CR16","doi-asserted-by":"publisher","first-page":"224ra24","DOI":"10.1126\/scitranslmed.3007094","volume":"6","author":"C Bettegowda","year":"2014","unstructured":"Bettegowda C, Sausen M, Leary RJ, Kinde I, Wang Y, Agrawal N et al (2014) Detection of circulating tumor DNA in early- and late-stage human malignancies. Sci Transl Med 6(224):224ra24","journal-title":"Sci Transl Med"},{"issue":"3","key":"1_CR17","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1593\/tlo.12445","volume":"6","author":"F Mouliere","year":"2013","unstructured":"Mouliere F, El Messaoudi S, Gongora C, Guedj AS, Robert B, Del Rio M et al (2013) Circulating cell-free DNA from colorectal cancer patients may reveal high KRAS or BRAF mutation load. Transl Oncol 6(3):319\u2013328","journal-title":"Transl Oncol"},{"key":"1_CR18","unstructured":"Thierry AR, Molina F (2011) Analytical methods for cell free nucleic acids and applications, PCT WO 2012\/028747, Sept 5"},{"key":"1_CR19","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.cca.2013.05.022","volume":"424","author":"S Messaoudi El","year":"2013","unstructured":"El Messaoudi S, Rolet F, Mouliere F, Thierry AR (2013) Circulating cell free DNA: preanalytical considerations. Clin Chim Acta 424:222\u2013230","journal-title":"Clin Chim Acta"},{"issue":"4","key":"1_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1373\/clinchem.2008.112797","volume":"55","author":"SA Bustin","year":"2009","unstructured":"Bustin SA, Benes V, Garson JA et al (2009) The MIQE guidelines: minimum information for publication of quantitative real-time PCR experiments. Clin Chem 55(4):611\u2013622","journal-title":"Clin Chem"},{"issue":"7","key":"1_CR21","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.molmed.2012.05.001","volume":"18","author":"V Taly","year":"2012","unstructured":"Taly V, Pekin D, El Abed A et al (2012) Detecting biomarkers with microdroplet technology. Trends Mol Med 18(7):405\u2013416","journal-title":"Trends Mol Med"},{"issue":"10","key":"1_CR22","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1038\/nmeth.2633","volume":"10","author":"CM Hindson","year":"2013","unstructured":"Hindson CM, Chevillet JR, Briggs HA, Gallichotte EN, Ruf IK, Hindson BJ, Vessella RL, Tewari M (2013) Absolute quantification by droplet digital PCR versus analog real-time PCR. Nat Methods 10(10):1003\u20131005","journal-title":"Nat Methods"},{"issue":"4","key":"1_CR23","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1038\/nm.3511","volume":"20","author":"AR Thierry","year":"2014","unstructured":"Thierry AR, Mouliere F, El Messaoudi S, Mollevi C, Lopez-Crapez E, Rolet F et al (2014) Clinical validation of the detection of KRAS and BRAF mutations from circulating tumor DNA. Nat Med 20(4):430\u2013435","journal-title":"Nat Med"},{"key":"1_CR24","volume-title":"Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring","author":"F Mouliere","year":"2015","unstructured":"Mouliere F, Thierry AR, Larroque C (2015) Detection of genetic alterations by nucleic acid analysis: use of PCR and Mass spectroscopy-based methods. In: Gahan P (ed) Circulating nucleic acids in early diagnosis, prognosis and treatment monitoring. Springer, Dordrecht"},{"issue":"7404","key":"1_CR25","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/nature11156","volume":"486","author":"S Misale","year":"2012","unstructured":"Misale S, Yaeger R, Hobor S, Scala E, Janakiraman M, Liska D et al (2012) Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancer. Nature 486(7404):532\u2013536","journal-title":"Nature"},{"issue":"7404","key":"1_CR26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/nature11219","volume":"486","author":"LA Diaz","year":"2012","unstructured":"Diaz LA, Williams RT, Wu J, Kinde I, Hecht JR, Berlin J et al (2012) The molecular evolution of acquired resistance to targeted EGFR blockade in colorectal cancers. Nature 486(7404):537\u2013540","journal-title":"Nature"}],"container-title":["Methods in Molecular Biology","Clinical Applications of PCR"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-4939-3360-0_1","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T08:36:45Z","timestamp":1559378205000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-1-4939-3360-0_1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"ISBN":["9781493933587","9781493933600"],"references-count":26,"URL":"https:\/\/doi.org\/10.1007\/978-1-4939-3360-0_1","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]},"assertion":[{"value":"4 February 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}